CN103103196A - Modified goat defensin gene and preparation method and application thereof - Google Patents

Modified goat defensin gene and preparation method and application thereof Download PDF

Info

Publication number
CN103103196A
CN103103196A CN2013100425083A CN201310042508A CN103103196A CN 103103196 A CN103103196 A CN 103103196A CN 2013100425083 A CN2013100425083 A CN 2013100425083A CN 201310042508 A CN201310042508 A CN 201310042508A CN 103103196 A CN103103196 A CN 103103196A
Authority
CN
China
Prior art keywords
goat
alexin
primer
gbd
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2013100425083A
Other languages
Chinese (zh)
Inventor
刘桂琼
姜勋平
刘胜敏
康建锋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Huazhong Agricultural University
Original Assignee
Huazhong Agricultural University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Huazhong Agricultural University filed Critical Huazhong Agricultural University
Priority to CN2013100425083A priority Critical patent/CN103103196A/en
Publication of CN103103196A publication Critical patent/CN103103196A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention discloses a modified goat defensin gene and a preparation method and an application thereof. The preparation method comprises the following steps of: modifying a goat defensin gene aiming at codon usage bias of pichia pastoris, so as to obtain the optimized goat defensin gene; and linking a target gene into a pPICZalphaA expression vector to obtain a recombinant expression plasmid pPICZalphaA/GBD-1, transferring the plasmid into the pichia pastoris, and obtaining an optimized goat defensin after inducing. The method is simple, feasible and suitable for mass production, the obtained goat defensin gene has an activity superior to a natural defensin and is low in cost, affordable in price and high in cost performance. The modified goat defensin gene can be used for replacing conventional antibiotics and some chemical preservatives and has great significances on food safety and clinic treatment.

Description

A kind of goat phylaxin gene and preparation method and application of modification
Technical field
The invention belongs to the genetically engineered field, be specifically related to a kind of goat phylaxin gene of modification, the goat alexin that also relates to a kind of modification also relates to a kind of alexinic preparation method of goat of modification, also relates to a kind of application of goat alexin on bacteria growing inhibiting of modification.
Background technology
Alexin is the little peptide that extensively is present in the organisms such as animal, plant and insect, and the defensin of present isolation identification is over 100 kinds.Alexin is the little cationic antibacterial peptide of a class, approximately is comprised of 21~45 amino-acid residues, and molecular weight is 3~6kD.Most of alexin molecules contain 6~8 conservative cysteine residues, form three pairs or four pairs of intramolecular disulfide bonds, and form a beta sheet sheet structure by intramolecular disulfide bond.Be rich in arginine, molecule is positively charged in neutral solution, have efficient, broad spectrum antibiotic activity, gram-positive microorganism, Gram-negative bacteria, fungi (Candida, genera cryptococcus, aspergillus), tunicle virus (hiv virus) etc. had certain killing effect, and can not make the microorganisms resistance, the cell of intact animal is shown nonspecific deleterious cellular effects.
Goat Reproductive road systemic disease is produced goat has larger harm, generally adopts at present microbiotic to treat.Due to a large amount of microbiotic that use, may produce Resistant strain and make and treat unsuccessfully in the goat body; Simultaneously, a large amount of microbiotic also may pollute and affect food safety sheep products such as mutton, goat milk.Alexin is small-molecule peptide, has broad spectrum antibiotic activity, and due to its special antibacterial mechanisms, body does not produce resistance to it, can solve the bacterial drug resistance problem, is antibiotic of new generation.
Content is seldom in animal and plant body for natural alexin, extract the cost of separating also very high, this has just restricted alexin suitability for industrialized production and the application in livestock and poultry, therefore by a large amount of production alexins of engineered method, obtain enough, activated alexin and become study hotspot.
Present many experiments are by engineered method, successfully phylaxin gene imported in various organisms and obtain good representation, such as mankind's alexin, porcine defensin, ox alexin etc. are all import to phylaxin gene in carrier for expression of eukaryon and expressed and apply for a patent, the alexin that gives expression to has biologic activity preferably.Not yet there is at present pair goat alexin to carry out the open report of a large amount of preparations of gene engineering method.
Summary of the invention
An object of the present invention is to be to provide a kind of goat phylaxin gene of modification, according to alexin sequence (GenBank:DQ532360.1), for the pichia spp codon preference, it is modified, obtained a kind of goat phylaxin gene of having optimized, its sequence is shown in SEQ ID NO.1.
A further object of the invention is the goat alexin that has been to provide a kind of modification, and its aminoacid sequence is that shown in SEQ ID NO.2, its activity is better than natural alexin, and is with low cost, the price material benefit, and cost performance is high.Alternative traditional microbiotic and the sanitas of some chemical have great importance to food safety and clinical treatment.
A further object of the invention is the alexinic preparation method of goat who has been to provide a kind of modification, and method is simple, and easily row, be suitable for scale operation.
Last purpose of the present invention has been to provide a kind of application of goat alexin on bacteria growing inhibiting of modification, by the processing of fibroin liquid that fresh meat is on the defensive, has improved greatly the fresh keeping time of meat.The lower fresh-keeping time of temperature is longer.
In order to achieve the above object, the present invention takes following technical measures:
1. the acquisition of the goat phylaxin gene of modifying:
According to goat phylaxin gene (GenBank:DQ532360.1), for the pichia spp codon preference, it is modified, obtained a kind of goat phylaxin gene of having optimized, its sequence is shown in SEQ ID NO.1.Design contains the primer of part complementary sequence, at primer two ends design EcoR I and two restricted interior restriction enzyme sites of Not I, obtains the GBD-1 gene of complete process modification by the method amplification of overlapping PCR.
Figure BDA00002815187100021
The primer sequence of design is as follows:
①:ACT GAATTCATGAGTCGTCGAAGCTGCCATAGGAATAAAGGCGTCTGTGCT
②:CTGTCTCATGTTTCTAGGGCATCTGGTCAGAGCACAGACGCCTTT
③:AACTGGGGGACCGAAACAGGTGCCAATCTGTCTCATGTTTCT
④:CAG GCGGCCGCCTTCTTTCTGCAGCATTTAACTGGGGGACCGAA
2. the Construction and identification of recombinant expression plasmid:
Correct purpose fragment and the pPICZ α A expression vector of order-checking carried out double digestion with EcoR I and Not I respectively, use T after enzyme is cut 4DNA ligase connects, and builds recombinant expression plasmid pPICZ α A/GBD-1.Recombinant expression plasmid is cultivated in containing the LB substratum of Zeocin, screened, extract plasmid with extracting in a small amount test kit, carry out double digestion, and recombinant expression plasmid pPICZ α A/GBD-1 is served the Hai Shenggong order-checking, check order correct, be recombinant expression plasmid pPICZ α A/GBD-1 of the present invention.
3. the conversion of recombinant plasmid:
With identifying that good recombinant expression plasmid pPICZ α A/GBD-1 with the linearizing of Sac I, in the transformed competence colibacillus pichia spp, utilizes electroporation to carry out electricity and turns, transform simultaneously pPICZ α A empty carrier in contrast.After turning, electricity coats in the YPD flat board that contains Zeocin, 30 ℃ have been cultured to single bacterium colony and have occurred, with single colony inoculation to containing Zeocin(100mg/mL) the YPD liquid nutrient medium in further cultivate, get the part bacterium colony, extract pastoris genomic dna, and utilize carrier special primer 5 ' AOX and 3 ' AOX to carry out PCR and identify, and order-checking.
5’AOX:GACTGGTTCCAATTGACAAGC
3’AOX:GCAAATGGCATTCTGACATCC
4. the abduction delivering of recombination yeast:
The positive recombinant bacterial strain that screening is good is inoculated into and activates 15h in the BMGY nutrient solution, centrifugal, remove supernatant, precipitation is induced after suspending with the BMMY nutrient solution, it is 1ml bacterium liquid two pipes after 1%, 84h that every 24h adds methyl alcohol to final concentration, the centrifugal supernatant that stays, obtained a kind of goat alexin of modification, its sequence is shown in SEQ ID NO.2.-20 ℃ of preservations.
5. sample is carried out preliminary activity identification:
Inject respectively the unloaded albumen of 20 μ L, recombinant secretor albumen, the 20 μ L100 μ g/mLAmp that 20 μ L induce 72h at the punch position of LB substratum, observe discovery after cultivating 10h, inhibition zone has all appearred in the hole of recombinant secretor albumen and Amp, can find out from the A culture plate, the strong resistance of the recombinant secretor albumen of Chinese People's Anti-Japanese Military and Political College's enterobacteria Performance Ratio equal volume of Amp (antibacterial circle diameter of recombinant secretor albumen is 1.9cm, and the antibacterial circle diameter that contains Amp is 2.7cm); Can find out the strong resistance of the recombinant secretor albumen of the anti-Staphylococcus aureus Performance Ratio equal volume of Amp (antibacterial circle diameter of recombinant secretor albumen is 2.1cm, and the antibacterial circle diameter that contains Amp is 5.0cm) from the B culture plate; A culture plate and B the culture plate just bacterium colony of growth are different, and other conditions are all identical, therefore can draw by recombinant secretor albumen inhibition zone in A and B culture plate, alexin to the restraining effect of streptococcus aureus greater than to colibacillary restraining effect.
Simultaneously inject respectively the unloaded albumen of 20 μ L, recombinant secretor albumen, the not modified goat alexin protein of 20 μ L that 20 μ L induce 72h at the punch position of LB substratum, observe discovery after cultivating 10h, inhibition zone has all appearred in recombinant secretor albumen and former alexinic hole, can find out the former alexin strong resistance of Chinese People's Anti-Japanese Military and Political College's enterobacteria Performance Ratio equal volume of recombinant secretor albumen from the C culture plate; Can find out from the D culture plate, the Performance Ratio of the anti-streptococcus pneumoniae of recombinant secretor albumen a little less than, but be eager to excel than the former defence fibroin of equal volume; Can find out from the E culture plate, recombinant secretor albumen is the activity of anti-pichia spp not substantially.(Fig. 1).
Result of study shows that alexin all has restraining effect to streptococcus aureus, intestinal bacteria and streptococcus pneumoniae.
The alexinic application on bacteria growing inhibiting of a kind of goat of modification, its application process is:
Adopt fresh pork, protein extract (concentration is 0.1mg/mL), use and adopt simple and easy to do spraying fresh-keeping method, protein extract is contained in the atomizer of sterilization, then be sprayed at equably on the pork surface, be contained in food bag after slightly dried, be placed in room temperature, 37 degree, 4 degree and minus 20 degrees, observe the variation of yellowish pink, smell and viscosity.Establish simultaneously non-processor control group and deionized water control group.37 degree control groups are rotten after 37 degree 2h, and experimental group is inferior bright; Control group is rotten when room temperature 6h, and experimental group is rotten after 8h; Control group went bad on the 8th day when 4 spend, and experimental group is normal; Went bad afterwards in 91 days at subzero 20 degree control group, experimental group is normal.
Compared with prior art, the present invention has the following advantages:
Goat alexin encoding sequence is optimized transformation, has obviously improved the expression level of alexin in pichia spp, be conducive to alexinic suitability for industrialized production and apply.Alexin is the immunity system that comes from animal body self, to the cell of animal own without toxic side effect, safe, therefore do not have the Biosafety problem.If be applied, have great economy and ecological benefits.
In the present invention, alexinic recombinant product activity is better than natural alexin; With low cost, the price material benefit, cost performance is high.Use present method to carry out bulk fermentation production to alexin, might substitute traditional microbiotic and the sanitas of some chemical, food safety and clinical treatment are had great importance.
Description of drawings
Fig. 1 is a kind of antibacterial effect schematic diagram of GBD-1 albumen
A: the restructuring alexin of modification is to colibacillary bacteriostatic action; B: the bacteriostatic action of the restructuring alexin of modification to streptococcus aureus; C: the alexin of modification and former alexin are to colibacillary antibacterial comparison; D: the alexin of modification and the former alexin antibacterial comparison to streptococcus pneumoniae; E: the alexin of modification and the former alexin antibacterial comparison to pichia spp.
1: unloaded albumen control group, 2: recombinant protein GBD-1,3:Amp control group, 4: former alexin control group
Fig. 2 determination of protein concentration typical curve
Typical curve R 2=0.994, comparatively ideal is described, X-axis represents standard substance concentration, Y-axis represents the OD value.
Fig. 3 Escherichia coli Growth graphic representation
X-axis represents Measuring Time, and Y-axis represents the OD value.Be followed successively by from top to bottom alexin, the contrast of LB liquid nutrient medium of former alexin control group, modification.
Embodiment
Embodiment 1:
The acquisition of the goat phylaxin gene of modifying:
According to goat phylaxin gene sequence (GenBank:DQ532360.1), for the pichia spp codon preference, it is modified, obtained a kind of goat phylaxin gene of having optimized, its sequence is shown in SEQ ID NO.1.Design contains the primer 1,2,3,4 of part complementary sequence, at primer two ends design EcoR I and two restricted interior restriction enzyme sites of Not I, obtains the GBD-1 gene of complete process modification by the method amplification of overlapping PCR.
The pcr amplification of GBD-1 gene: primer 1,2,3 template and primer each other carries out PCR, reaction system is: primer 1,2,3(concentration are all 10 μ mol/L) add respectively 2 μ L, 1 μ L, 2 μ L, 2.5mM dNTPs3.5 μ L, 10 * EasyTaq Buffer5 μ L, EasyTaq DNA Polymerase1 μ L mends aseptic double-distilled water to 50 μ L.
Amplification condition: 94 ℃ of denaturation 4min; 94 ℃ of 30s, 62 ℃ of 30s, 72 ℃ of 30s, 32 circulations; 72 ℃ are fully extended 10min.
The PCR product reclaims test kit with the DNA gel purifying and reclaims the purpose fragment after 2% (w/v) agarose gel electrophoresis, is numbered 1-2-3.
Template and primer carry out PCR each other again for primer 1,1-2-3,4, reaction system is: primer 1,1-2-3,4 add respectively 2 μ L, 1 μ L, 2 μ L, 2.5mM dNTPs3.5 μ L, 10 * EasyTaq Buffer5 μ L, EasyTaq DNA Polymerase1 μ L mends aseptic double-distilled water to 50 μ L.
Amplification condition: 94 ℃ of denaturation 4min; 94 ℃ of 30s, 62 ℃ of 30s, 72 ℃ of 30s, 32 circulations; 72 ℃ are fully extended 10min.
The PCR product reclaims test kit with the DNA gel purifying and reclaims the purpose fragment after 2.0% (w/v) agarose gel electrophoresis, and this purpose fragment is the goat alexin aim sequence of modification.
Figure BDA00002815187100051
The primer sequence of design is as follows:
1:ACT GAATTCATGAGTCGTCGAAGCTGCCATAGGAATAAAGGCGTCTGTGCT
2:CTGTCTCATGTTTCTAGGGCATCTGGTCAGAGCACAGACGCCTTT
3:AACTGGGGGACCGAAACAGGTGCCAATCTGTCTCATGTTTCT
4:CAG GCGGCCGCCTTCTTTCTGCAGCATTTAACTGGGGGACCGAA
Embodiment 2:
The Construction and identification of recombinant expression plasmid:
Correct purpose fragment and the pPICZ α A expression vector of order-checking carried out double digestion with EcoR I and Not I respectively, use T after enzyme is cut 4DNA ligase connects, and builds recombinant expression plasmid pPICZ α A/GBD-1.Recombinant expression plasmid is cultivated in containing the LB substratum of Zeocin, screened, extract plasmid with extracting in a small amount test kit, carry out double digestion, and recombinant expression plasmid pPICZ α A/GBD-1 is served the Hai Shenggong order-checking, check order correct, be recombinant expression plasmid pPICZ α A/GBD-1 of the present invention.
Embodiment 3:
The conversion of recombinant plasmid:
With identifying that good recombinant expression plasmid pPICZ α A/GBD-1 with the linearizing of Sac I, in the transformed competence colibacillus pichia spp, utilizes electroporation to carry out electricity and turns, transform simultaneously pPICZ α A empty carrier in contrast.After turning, electricity coats in the YPD flat board that contains Zeocin, 30 ℃ have been cultured to single bacterium colony and have occurred, with single colony inoculation to containing Zeocin(100mg/mL) the YPD liquid nutrient medium in further cultivate, get the part bacterium colony, extract pastoris genomic dna, and utilize carrier special primer 5 ' AOX and 3 ' AOX to carry out PCR and identify, and order-checking.
5’AOX:GACTGGTTCCAATTGACAAGC
3’AOX:GCAAATGGCATTCTGACATCC
Embodiment 4:
The abduction delivering of recombination yeast:
The positive recombinant bacterial strain that screening is good is inoculated into and activates 15h in the BMGY nutrient solution, centrifugal, remove supernatant, precipitation is induced after suspending with the BMMY nutrient solution, it is 1ml bacterium liquid two pipes after 1%, 84h that every 24h adds methyl alcohol to final concentration, the centrifugal supernatant that stays, obtained a kind of goat alexin of modification, its sequence is shown in SEQ ID NO.2.-20 ℃ of preservations.
Embodiment 5:
The detection of expression product:
To a collection of bacterium liquid TCA(trichoroacetic acid(TCA) after inducing) 4 ℃ of concentrated spending the night, the centrifugal supernatant of abandoning, add 2 * SDS-PAGE sample-loading buffer, boil 10min after mixing up the pH value with NaOH, carry out Tricine-SDS-PAGE electrophoresis and Western Blot and detect, another batch bacterium liquid is measured protein concentration with the BCA method and is utilized Agarose cavity diffusion method to carry out the bacteriostatic activity detection to streptococcus aureus and intestinal bacteria.The pure alexin of preparation has good anti-microbial activity.
Get the 2 μ L protein standard substances protein standard curve of completing, R 2=0.994, the description standard curve is comparatively desirable, can be used for measuring protein sample concentration (Fig. 2), then get 2 μ L testing proteins, is determined at OD value and protein concentration under 562nm, the results are shown in Table 1.
Table 1 determination of protein concentration result
Figure BDA00002815187100071
Embodiment 6:
Antibacterial result detects:
1, Agarose cavity diffusion method
Inject respectively the unloaded albumen of 20 μ L, recombinant secretor albumen, the 20 μ L100 μ g/mLAmp that 20 μ L induce 72h at the punch position of LB substratum, observe discovery after cultivating 10h, inhibition zone has all appearred in the hole of recombinant secretor albumen and Amp, can find out from the A culture plate, the strong resistance of the recombinant secretor albumen of Chinese People's Anti-Japanese Military and Political College's enterobacteria Performance Ratio equal volume of Amp (antibacterial circle diameter of recombinant secretor albumen is 1.9cm, and the antibacterial circle diameter that contains Amp is 2.7cm); Can find out the strong resistance of the recombinant secretor albumen of the anti-Staphylococcus aureus Performance Ratio equal volume of Amp (antibacterial circle diameter of recombinant secretor albumen is 2.1cm, and the antibacterial circle diameter that contains Amp is 5.0cm) from the B culture plate; A culture plate and B the culture plate just bacterium colony of growth are different, and other conditions are all identical, therefore can draw by recombinant secretor albumen inhibition zone in A and B culture plate, alexin to the restraining effect of streptococcus aureus greater than to colibacillary restraining effect.
Simultaneously inject respectively the unloaded albumen of 20 μ L, recombinant secretor albumen, the not modified goat alexin protein of 20 μ L that 20 μ L induce 72h at the punch position of LB substratum, observe discovery after cultivating 10h, inhibition zone has all appearred in recombinant secretor albumen and former alexinic hole, can find out the former alexin strong resistance of Chinese People's Anti-Japanese Military and Political College's enterobacteria Performance Ratio equal volume of recombinant secretor albumen from the C culture plate; Can find out from the D culture plate, the Performance Ratio of the anti-streptococcus pneumoniae of recombinant secretor albumen a little less than, but be eager to excel than the former defence fibroin of equal volume; Can find out from the E culture plate, recombinant secretor albumen is the activity of anti-pichia spp not substantially.(Fig. 1).
2, minimal inhibitory concentration is measured:
50 μ L protein samples difference doubling dilutions in each experimental port of 96 orifice plates, are then added the test bacterium liquid of 100 μ L106CFU/mL, and control group is established two groups: one group is 100 μ L nutrient solutions; Another group is 100 μ L bacterium liquid, and 37 ℃, 220r/min shaking table were cultivated 12 hours, at λ=595nm detection optical density value OD, the results are shown in Table 2 with automatic microplate reader.
The MIC value of the alexin that table 2 is modified to five kinds of different strains
3, the impact of growth curve:
50 μ L protein samples difference doubling dilutions in each experimental port of 96 orifice plates, are added the test bacterium liquid of 100 μ L106CFU/mL, and control group is established two groups: one group is 100 μ L nutrient solutions; Another group is 100 μ L bacterium liquid, and 37 ℃, 220r/min shaking table were cultivated 12 hours, every 2h with automatic microplate reader at λ=595nm detection optical density value OD.Do three times and average, draw intestinal bacteria ATCC25922 growth curve charts (Fig. 3).Result shows that alexin has restraining effect to colibacillary growth, particularly acts on stationary phase, and the alexin protein liquid of modifying is stronger to colibacillary effect than former alexin.
Embodiment 7:
The alexinic application on bacteria growing inhibiting of a kind of goat of modification, its application process is:
Adopt fresh pork, protein extract of the present invention (concentration is 0.1mg/mL), use and adopt simple and easy to do spraying fresh-keeping method, protein extract is contained in clean atomizer, then be sprayed at equably on the pork surface (0.5ml/g), be contained in food bag after slightly dried, be placed in room temperature, 37 degree, 4 degree and minus 20 degrees, observe the variation of yellowish pink, smell and viscosity.Establish simultaneously non-processor control group and deionized water control group.37 degree control groups are rotten after 37 degree 2h, and experimental group is inferior bright; Control group is rotten when room temperature 6h, and experimental group is rotten after 8h; Control group went bad on the 8th day when 4 spend, and experimental group is normal; Went bad afterwards in 91 days at subzero 20 degree control group, experimental group is normal.
SEQUENCE LISTING
<110〉Hua Zhong Agriculture University
<120〉a kind of goat phylaxin gene and preparation method and application of modification
<130〉a kind of goat phylaxin gene and preparation method and application of modification
<160> 6
<170> PatentIn version 3.1
<210> 1
<211> 114
<212> DNA
<213〉synthetic
<400> 1
agtcgtcgaa gctgccatag aaataaaggc gtctgtgctc tgaccagatg ccctagaaac 60
atgagacaga ttggcacctg tttcggtccc ccagttaaat gctgcagaaa gaag 114
<210> 2
<211> 38
<212> PRT
<213〉synthetic
<400> 2
Ser Arg Arg Ser Cys His Arg Asn Lys Gly Val Cys Ala Leu Thr Arg
1 5 10 15
Cys Pro Arg Asn Met Arg Gln Ile Gly Thr Cys Phe Gly Pro Pro Val
20 25 30
Lys Cys Cys Arg Lys Lys
35
<210> 3
<211> 51
<212> DNA
<213〉synthetic
<400> 3
actgaattca tgagtcgtcg aagctgccat aggaataaag gcgtctgtgc t 51
<210> 4
<211> 45
<212> DNA
<213〉synthetic
<400> 4
ctgtctcatg tttctagggc atctggtcag agcacagacg ccttt 45
<210> 5
<211> 42
<212> DNA
<213〉synthetic
<400> 5
aactggggga ccgaaacagg tgccaatctg tctcatgttt ct 42
<210> 6
<211> 44
<212> DNA
<213〉synthetic
<400> 6
caggcggccg ccttctttct gcagcattta actgggggac cgaa 44

Claims (7)

1. the goat phylaxin gene of the modification of a synthetic, its sequence is shown in SEQ ID NO.1.
2. the goat alexin of a modification, its sequence is the aminoacid sequence shown in SEQ ID NO.2.
3. the alexinic preparation method of the goat of a kind of modification claimed in claim 2, the steps include:
1) GBD-The pcr amplification of 1 gene: primer 1,2,3 template and primer each other carries out PCR, and reaction system is: primer 1,2,3 adds respectively 2 μ L, 1 μ L, 2 μ L, 2.5 mM dNTPs 3.5 μ L, 10 * EasyTaqBuffer 5 μ L, EasyTaqDNA Polymerase 1 μ L mends aseptic double-distilled water to 50 μ L;
Amplification condition: 94 ℃ of denaturation 4 min; 94 ℃ of 30 s, 62 ℃ of 30 s, 72 ℃ of 30 s, 32 circulations; 72 ℃ are fully extended 10 min;
The PCR product reclaims test kit with the DNA gel purifying and reclaims the purpose fragment after the agarose gel electrophoresis of 2 % mass volume ratios, is numbered 1-2-3;
Primer 1,1-2-3,4 more each other template and primer carry out PCR, reaction system is: primer 1,1-2-3,4 add respectively 2 μ L, 1 μ L, 2 μ L, 2.5 mM dNTPs 3.5 μ L, 10 * EasyTaqBuffer 5 μ L, EasyTaqDNA Polymerase 1 μ L mends aseptic double-distilled water to 50 μ L;
Amplification condition: 94 ℃ of denaturation 4 min; 94 ℃ of 30 s, 62 ℃ of 30 s, 72 ℃ of 30 s, 32 circulations; 72 ℃ are fully extended 10 min;
The PCR product reclaims test kit with the DNA gel purifying and reclaims the purpose fragment after the agarose gel electrophoresis of 2.0 % mass volume ratios, and this purpose fragment is the goat alexin aim sequence of modification;
Described primer is:
1:ACT GAATTCATGAGTCGTCGAAGCTGCCATAGGAATAAAGGCGTCTGTGCT
2:CTGTCTCATGTTTCTAGGGCATCTGGTCAGAGCACAGACGCCTTT
3:AACTGGGGGACCGAAACAGGTGCCAATCTGTCTCATGTTTCT
4:CAG GCGGCCGCCTTCTTTCTGCAGCATTTAACTGGGGGACCGAA;
2) Construction and identification of recombinant expression plasmid:
Correct purpose fragment and the pPICZ α A expression vector of order-checking carried out double digestion with EcoR I and Not I respectively, use T after enzyme is cut 4DNA ligase connects, and builds recombinant expression plasmid pPICZ α A/GBD-1; Recombinant expression plasmid is cultivated in containing the LB substratum of Zeocin, screened, extract plasmid with extracting in a small amount test kit, carry out double digestion, and recombinant expression plasmid pPICZ α A/GBD-1 is checked order, check order correct, be recombinant expression plasmid pPICZ α A/GBD-1;
3) conversion of recombinant plasmid:
With identifying that good recombinant expression plasmid pPICZ α A/GBD-1 with the linearizing of Sac I, in the transformed competence colibacillus pichia spp, utilizes electroporation to carry out electricity and turns, transform simultaneously pPICZ α A empty carrier in contrast; After turning, electricity coats in the YPD flat board that contains Zeocin, 30 ℃ have been cultured to single bacterium colony and have occurred, single colony inoculation is further cultivated in the YPD liquid nutrient medium that contains Zeocin, get the part bacterium colony, extract pastoris genomic dna, and utilize carrier special primer 5 ' AOX and 3 ' AOX to carry out PCR and identify, and order-checking;
5’AOX:GACTGGTTCCAATTGACAAGC
3’AOX:GCAAATGGCATTCTGACATCC;
4) abduction delivering of recombination yeast:
The positive recombinant plasmid that obtains in step 3) is inoculated in the BMGY nutrient solution activates 15h, centrifugal, remove supernatant, precipitation is induced after suspending with the BMMY nutrient solution, and it is 1ml bacterium liquid two pipes after 1%, 84h that every 24h adds methyl alcohol to final concentration, the centrifugal supernatant that stays ,-20 ℃ of preservations.
4. goat alexin claimed in claim 2 is in the application that suppresses on Escherichia coli Growth.
5. goat alexin claimed in claim 2 is in the application that suppresses on staphylococcus aureus growth.
6. goat alexin claimed in claim 2 is in the application that suppresses on the pneumonia streptococcus bacteria growing.
7. the application of goat alexin claimed in claim 2 on pork is fresh-keeping.
CN2013100425083A 2013-02-04 2013-02-04 Modified goat defensin gene and preparation method and application thereof Pending CN103103196A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2013100425083A CN103103196A (en) 2013-02-04 2013-02-04 Modified goat defensin gene and preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2013100425083A CN103103196A (en) 2013-02-04 2013-02-04 Modified goat defensin gene and preparation method and application thereof

Publications (1)

Publication Number Publication Date
CN103103196A true CN103103196A (en) 2013-05-15

Family

ID=48311392

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2013100425083A Pending CN103103196A (en) 2013-02-04 2013-02-04 Modified goat defensin gene and preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN103103196A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103710277A (en) * 2013-11-26 2014-04-09 姜勋平 Saccharomyces cerevisiae gene engineering bacteria and use thereof
CN110386971A (en) * 2018-04-17 2019-10-29 四川农业大学 A kind of channel catfish beta-alexin recombinant protein and its preparation method and application
CN111153982A (en) * 2020-02-17 2020-05-15 西北农林科技大学 Ruminant rumen specific antibacterial peptide DEFB1 and application thereof
RU2722849C1 (en) * 2019-12-25 2020-06-04 Владимир Глебович Лунин Recombinant protein gbd-sstad-sstad, a method for production and use thereof
CN114262363A (en) * 2021-12-22 2022-04-01 杭州科元生物医药有限公司 Biological defensin and application thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101275118A (en) * 2007-12-13 2008-10-01 河北农业大学 Preparation method of porcine defensin yeast engineering bacteria
CN102603885A (en) * 2011-12-26 2012-07-25 中国科学院遗传与发育生物学研究所 Alexin and application thereof to preparation of antibacterial medicament

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101275118A (en) * 2007-12-13 2008-10-01 河北农业大学 Preparation method of porcine defensin yeast engineering bacteria
CN102603885A (en) * 2011-12-26 2012-07-25 中国科学院遗传与发育生物学研究所 Alexin and application thereof to preparation of antibacterial medicament

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ZHAO,C.,ET AL.: "O97946", 《GENBANK》 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103710277A (en) * 2013-11-26 2014-04-09 姜勋平 Saccharomyces cerevisiae gene engineering bacteria and use thereof
CN110386971A (en) * 2018-04-17 2019-10-29 四川农业大学 A kind of channel catfish beta-alexin recombinant protein and its preparation method and application
RU2722849C1 (en) * 2019-12-25 2020-06-04 Владимир Глебович Лунин Recombinant protein gbd-sstad-sstad, a method for production and use thereof
CN111153982A (en) * 2020-02-17 2020-05-15 西北农林科技大学 Ruminant rumen specific antibacterial peptide DEFB1 and application thereof
CN111153982B (en) * 2020-02-17 2022-05-31 西北农林科技大学 Ruminant rumen specific antibacterial peptide DEFB1 and application thereof
CN114262363A (en) * 2021-12-22 2022-04-01 杭州科元生物医药有限公司 Biological defensin and application thereof

Similar Documents

Publication Publication Date Title
CN112760253B (en) Lactobacillus plantarum, antibacterial peptide and application thereof
CN101705212B (en) N-acylhomoserine lactonas, production method thereof and special recombinant bacterium
CN104151415B (en) A kind of natural antibacterial peptide Alligatorin4 and its application
CN102524518B (en) Method for producing antibacterial peptide by using brevibacillus laterosporu
CN108148794B (en) Bacillus subtilis DYr3.3 with broad-spectrum antibacterial activity, and preparation method and application thereof
CN103103196A (en) Modified goat defensin gene and preparation method and application thereof
CN101104637B (en) Cecropin and its generation bacterial strain and use
CN103333819A (en) Bacillus subtilis capable of producing broad spectrum and efficient antibacterial peptide and application of Bacillus subtilis
CN103667106B (en) A kind of plant lactobacillus, its bacteriocin and cultivation and separation purification method
CN103333225A (en) Antibacterial peptide, preparation method and applications thereof
CN107857803A (en) Natural antibacterial peptide and its application
CN106995494A (en) A kind of efficient preparations of novel antimicrobial peptide Mytichitin A in Pichia pastoris
CN103214583A (en) Secretory expression method of bacteriocin lacticin Q
CN101812459A (en) Nucleic acid for encoding antimicrobial peptide Lactoferricin B and prokaryotic expression method thereof
CN104140458B (en) One kind cecropin antimicrobial peptides and application thereof
CN102586262B (en) Defensin gene of antimicrobial peptide of bemisia tabaci (Gennadius), antimicrobial peptide encoded by defensin gene and preparation method for defensin gene
CN101328207B (en) Citrus fruit fly antibacterial peptide, preparation and use thereof
CN105104712B (en) A kind of additive for microbe feedstuff and preparation method thereof
CN104530204B (en) A kind of rape cecropin B gene nPRP1 and its application
CN107325158B (en) Antibacterial peptide CNAP- I, antibacterial peptide CNAP- II and its preparation method and application
CN105274128A (en) Method for utilizing genetic engineering high-efficiency expression to amidate EC07
CN102061303A (en) Fusion expression product of antimicrobial peptide genes of two marine animals and preparation method of fusion expression product
CN109305996A (en) Fusarium graminearum secreted protein exciton FgHrip1 and its application
CN105732792A (en) Yeast expressed chicken Cathelicidin antibacterial peptide as well as preparation method and application thereof
CN102925505B (en) Method for preparing highly-purified L-Lysine sulphate through one-time fermentation

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20130515